CFDE Data Portal | Search SRP14

	Label	Description
	SRP14 Gene (Entity type)	ENSG00000140319 - signal recognition particle 14
	SRP14 associations Collection (Entity type)	Associations for SRP14_associations
	SRP14-DT Gene (Entity type)	ENSG00000248508 - SRP14 divergent transcript
	SRP14 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SRP14-AS1 associations Collection (Entity type)	Associations for SRP14-AS1_associations
	GSE166914 1 V 2 ABEMACICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 5 V 0 TUNICAMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158632 3 V 5 OXYQUINOLINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

SRP14

ENSG00000140319 - signal recognition particle 14

SRP14 associations

Associations for SRP14_associations

SRP14-DT

ENSG00000248508 - SRP14 divergent transcript

SRP14 associations.tsv

A file from IDG as part of the Harmonizome project

SRP14-AS1 associations

Associations for SRP14-AS1_associations

GSE166914 1 V 2 ABEMACICLIB HUMAN DN

A Gene Set from LINCS

GSE102505 5 V 0 TUNICAMYCIN HUMAN DN

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN DN

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn

A Gene Set from LINCS

GSE158632 3 V 5 OXYQUINOLINE HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.